Global Clinical Trials Matching Software Market Size Worth USD 582.80 Million by 2033 | CAGR of 13.46%
Category: HealthcareGlobal Clinical Trials Matching Software Market Size To Worth USD 582.80 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Clinical Trials Matching Software Market Size is Expected to Grow from USD 164.83 Million in 2023 to USD 582.80 Million by 2033, at a CAGR of 13.46% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 266 pages with 110 Market data tables and figures & charts from the report on the "Global Clinical Trials Matching Software Market Size, Share, and COVID-19 Impact Analysis, By Deployment Mode (Web & Cloud-Based and On-Premise), By End User (Pharmaceutical & Biotechnology Companies, CROs, and Medical Device Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/clinical-trials-matching-software-market
The clinical trials matching software market is the sector that creates and deploys specialized software solutions to facilitate the process of matching patients, physicians, or research participants with suitable clinical trials. Apps that utilise data analytics, artificial intelligence, and complex algorithms to boost clinical trial success rates, expedite recruiting processes, and enhance accessibility are available on the market for these devices. The increasing number of clinical studies being carried out globally is anticipated to propel the clinical trials matching software market. Some of the main factors driving the growth of the clinical trials matching software market include the need to increase trial efficiency, the increasing complexity of clinical trials, the use of AI and machine learning in patient recruitment, and the growing demand for advanced treatment solutions due to the rising incidence of chronic diseases. However, regulatory obstacles, interoperability issues, implementation costs, data privacy concerns, ignorance, and reluctance to accept new technologies are some of the restraining factors in the clinical trials matching software market.
The web & cloud-based segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the deployment mode, the clinical trials matching software market is classified into web & cloud-based, and on-premise. Among these, the web & cloud-based segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. The cloud computing paradigm is responsible for the web & cloud-based sector as it is simple to operate and requires no maintenance costs. Researchers, hospitals, and patients are just a few of the stakeholders that may collaborate, share data in real time, and integrate seamlessly with these systems.
The pharmaceutical & biotechnology companies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the end user, the clinical trials matching software market is divided into pharmaceutical & biotechnology companies, CROs, and medical device companies. Among these, the pharmaceutical & biotechnology companies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. In order to expedite their clinical development pipeline and improve trial accuracy and success rate, pharmaceutical companies use AI-driven systems to effectively match patients with suitable trials.
North America is estimated to hold the largest share of the clinical trials matching software market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the clinical trials matching software market over the forecast period. The region's focus on customized treatment is reinforced by the expanding trend of patient-centric studies and the emergence of telemedicine, which both encourage the use of clinical trial matching software.
Asia Pacific is predicted to grow at the fastest CAGR in the clinical trials matching software market over the forecast period. The implementation of these technologies is being driven by government programs to fund clinical research and the expansion of healthcare infrastructure.
Major key players in the clinical trials matching software market include IBM, Microsoft, Clario, Advarra, Curewiki, Inteliquet (IQVIA), Evidation Health, Inc., Tempus Labs, ArisGlobal, Teckro Limited, HealthMatch, Inspirata, Inc., Mendel Health Inc., Ofni Systems, MatchTrial, Antidote Technologies, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In September 2023, to expedite the matching process for cancer clinical trials, the Israeli organization Belong. Life launched Tara, a conversational AI tool. Tara interacts with patients, collects pertinent health information, and makes tailored trial suggestions based on each person's unique profile using cutting-edge AI.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the clinical trials matching software market based on the below-mentioned segments:
Global Clinical Trials Matching Software Market, By Deployment Mode
- Web & Cloud-based
- On-premise
Global Clinical Trials Matching Software Market, By End User
- Pharmaceutical & Biotechnology Companies
- CROs
- Medical Device Companies
Global Clinical Trials Matching Software Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?